pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3179-1 |
Genomic Coordinates | chr16: 14901508 - 14901591 |
Description | Homo sapiens miR-3179-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-2 |
Genomic Coordinates | chr16: 16300159 - 16300242 |
Description | Homo sapiens miR-3179-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-3 |
Genomic Coordinates | chr16: 18411894 - 18411977 |
Description | Homo sapiens miR-3179-3 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-4 |
Genomic Coordinates | chr16: 18494493 - 18494576 |
Description | Homo sapiens miR-3179-4 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3179 | |||||||||||||||
Sequence | 52| AGAAGGGGUGAAAUUUAAACGU |73 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF366 | ||||||||||||||||||||
Synonyms | DC-SCRIPT, DCSCRIPT | ||||||||||||||||||||
Description | zinc finger protein 366 | ||||||||||||||||||||
Transcript | NM_152625 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF366 | |||||||||||||||||||||
3'UTR of ZNF366 (miRNA target sites are highlighted) |
>ZNF366|NM_152625|3'UTR 1 GTGGACAGTTTTAAAATTACATTTGGAAAATGAGAAGGAGGCAGTTCAAATATAGCTTTCTGCATGAACTGTCATTTTCT 81 GGAGACTGGCGAATAGTACCAATCTCTACAAATGGCTTAGACTAAATGAGCAGGGATGTAGGTAATGGAAAGCCTTCTCA 161 GGTCATTCACGGGGCCCTTGATACCCTTCACACATGTGCAGGGTCTTCATCAGTGGCGTTTTATGCATTGCCAGTATAAT 241 AAACTGTGAGTATTCTTCCAGATATCTAATTGTAAGCTGATGCTGAGGTGCTTTTAGAAATTCTACTTTCCTTTGATTCA 321 TATGCAATACATGGTAAATTTCTAATTGCAAAAATATGGTGCTTGAGGTGTCACCTTATTAATAACTATTTAGGTGAATT 401 TGTGAAGGTTATAATATTTTCCATATAGATGAAAATATTAGTCGTCATATATATAAAAATAGCCTTTATTCTATAACCAA 481 AAATGTCAGAAATGGCACAGGAGGATGAGCTATTGAAGAGAATGCTCTCCAGTAGTTGCTGCAGATATAAGGTAAAATTT 561 CAGGAGAAGAATAATTTTGACTAAGGGAAACTGGTGACCTAGAATACTTAGATTCTCTTGTTCTGTGTCGGCTGTCTTCA 641 TCAGATTGAGCATTTGGAGCATTATTTTTCAGATGATATGATGATGTTTGGGGCCCTGGCTCCTCAGACAAACCCTCACT 721 TCTCGAGCACGGCTCCCTCCTGGAGACCATTGCTGTCTTGCTCTGAGGCCTCATGCCCCATAAGACAGATGCAGGGGCCG 801 GGCGCAGAGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCAGGCAGATCACTTGAGGTCAGGAGTTTGAGAC 881 CAACCTGGCCAACGTGGCAAAACCCCTTCTCTACTAAAAATACAAAAATTAGCCAGGCATGATGGCAGGAGCCTGTAGTT 961 CCAGCTACTCGGGAGGCTGAAGCAGGAGAATCGTTTGAACCCAGGCAGTGGAGATTGCAGTGAGCTGAGCTGAGATCACG 1041 CTACTGCACTACAGCCTGGGTGACAGAGTGAGACTCTGCCTCAAAAAAAAAAAAAAAAAAAAAAGGACAGATGCAGGAAG 1121 ACTTGTCACCAGTGACCAGGGGGCTTTCTCCTCAGAGCTAGAGCTGGGGGGGTGACCTCAGAGAATTCTCCCAGAAATCT 1201 AAGCTCTGACTTATTTGGGGTACTAGAATAGTTGACAGCAAATCATTAGTAAAGAAGACTCTGGACTGTGTTTTCAGTGC 1281 TGGCTGTACATTAGAAGCATCTGGGGTGACCTTTAAAAAAAAACCACCAAACCAAGGCCTTACCCATTAAGATTCTGATT 1361 TAATTGATCTGGAGTGGAGCCCTAGGACTGAAATTTTCCAAATTGCTCCTGGCAATTCTTATGTGCAGCCAAGATTGAGA 1441 AGATTGAGGGGACTAAAATAGAACTCACCATTTCTGTGGCTTCCAGGACACTTCCCAGAGACTTCATAAGTATTTCTGTT 1521 CCTAGCCTCAGACTCTTTAAGGTTGAGAATAGGAGACCTCACAATCATACTGCTGACTTAGGCTTTCTTACCTGTCTGTA 1601 AGAGCCTTATGAGCGGACACACACAGTCTATATATAGATACACACTTTTTACATTATACTAGAAGATGATGCCTGTGATG 1681 TTTATGGTCACTTACTATGTTTAAAAAATGCATGACTGGCCTATGGTGACTCATTATTTCTTCCCAGATGCTTGAACCAT 1761 GATGCCAGTGAGTGGAAATGACTCTATTGGGTGGGATGGGCCCAGCAGGTCAGACTTACTTAGGCACTGGCACTGAGAAA 1841 AGCAATACTGACTGGGTGTCGTGTACGTGTGACTGCCCATAGCAATAACCCTCTGGTACTGTGTCTGTTTATGTAAAAAC 1921 TTCTTGTTTGGTAGTTTTGACTCGTATTTGTAGAGCTAGGTACTGGTTATTATTGTGCTTCATCCTATCCCAGATTTCCC 2001 AGTACATTCCTTTAGAAGACATGTCCATCTCCAACTGCTGGGGGCTGGCCTTTTCTGTAGGCCAAGGTGCTGCCCCATTA 2081 GCCCCACCTGGTTGTCATCACTCACCCATGTGTTGTGTCCATCTCTGACCCATTTCCCCTGCCACCTTGCCTAAAGCTTC 2161 TCCTGTCAGCCTCCCCACCACCATGAAGTGCTAAGAGTACTATGTCCTGAGGTAAGGGCACCTGCAACGGAGATTGTGAA 2241 GAGAAGACTGTGGGTTTCTGTGGTTACAAGCACAACTCTGGGTCAAAAACCCATTCCAAGTCCTCAGAGGGGCAAGTCCC 2321 TTCCATTCAGTATTAATATAGCTCATCAGTGCCTCTGATGAAATTGCCCAGGATGCTGGCAGTGTGGCCTGGGAGGCTTC 2401 CAGCTCTTGGGGTCTGGTTACACATTTATTCACACTGCGGCCATGTGTTGAGGACCTACTATGTGCTGTGTTTGACCACA 2481 CGTCCTGTAGAATGCCGTTTGGTTCTGAGTATGCCTGGCTGGAATGGAAACCAGGAAATTCTAGAGTAACAGGCTCTAGT 2561 CCTTTCCAACCAAAACAAACCTCATGGGAATGTTTGAGGGACCAGTTAATGTTGAGACAGAGAGAGTATGGTCTAGAATG 2641 GTGGTTTTCAGATTGTGTTTTGAGAAGCCAGAGGTCATCTTTAGGCCTCTGAAGAGTGGTAAGGGGAGGAGAAGCTCTCA 2721 ACTCCCACACCCACCTCACTCCAAGCAGCTCAAGTTCCATCTGATTTATACATTAGCATTCTAAGTAAAATTTTATTTGG 2801 AGGCAGTAAAAAGGTCTAGGAGAAATAAAAACAATTTGTTATGGAGTGTATTCCAGGGCCTGTTTTTAGTTGTTGACTCT 2881 GGGCATAAGACACTTAATTAGATCTAACCTGATGGTTAATACAGCATTAACCTGAGCACCAATGCTAAAACATTGGTTTT 2961 GTATGCTGTTGAGTGACCAACATCCTGGTTTGCCTGGGATGATCGTGGTTTAGACCTGTTGTCCCAGGATAATTATTCAA 3041 GTGTCACCTTAATTCTCAAAAGTATTCCAGTTTGGGTGAGAAATTACATGGACACTTTATGCAAGAGCACAGAGTTAAGG 3121 GAAGGGTTGGCCAGCCTTGCCTAATGAGCTGATGAACCAGAAGGCAAGCCTTGAAGGAGAGTCCATGTGGGCCATCTCAG 3201 AGAACTAAGGGATGAAGCCTTCCAAGATTACCAGCATTCCAAAACCAGAATATCATATTGTGAGACTCTGAAAATAGGTC 3281 ACTACCAAATGCTTTCCAGCCTTTTGACCACTGTCACTTTGAACAAATCAATGGACCAGCAAAGTGGCATATTTTTCTTT 3361 TATTCTTTTTATTCTTTCCTATGATTACTCCTCATGTTACCTTTCAATTCCTCTTTCTGTCTCTCTTTTTAAAAATTTGA 3441 CTCCCCACCGGCCATGAGACTAAGGCTGACCTTTCATAAACCCACAAGAGTAACTGGTATATTTGTATATGAGTAGTTGC 3521 ATGAGAAAGCTCAATGTGCATACTGTATTTATTAAGCCCTGAACGCATTTAATAAAATATTAACATGGTGTTTTGAATTA 3601 TGATCTTTGTCTGCTTTGCTGGAACAAAATATAACAGAGCTAACGTTTGAAATCCTTCGCATATTTGGACAACATTACAC 3681 CAAATGTTGATTTTGTACAGAACTCTGGCTTGCTATTTAAAAACTAAAACTCTAAGTATATAGCAGCCCAAGTTGTGAAT 3761 ATTGCTTTCTGCTTCACTGAAAAAGCAGTTTACCTGAAAAGAGCATGTAACCTATATTTTGTTAATTTAAGCAAATAAAG 3841 ACATGTTGAAAAAGCTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | hESCs (WA-09) | ||||||
Disease | 167465.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 167465.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000318442.5 | 3UTR | CAAAACCCCUUCUCUACUAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000318442.5 | 3UTR | AAAACCCCUUCUCUACUAAAAAUACAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-3179 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT102087 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT110061 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 6 | ||||||
MIRT112198 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT117668 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT146657 | MINK1 | misshapen like kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175505 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
![]() |
2 | 4 | ||||||
MIRT180535 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT190624 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT190650 | PABPN1 | poly(A) binding protein nuclear 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366902 | NONO | non-POU domain containing octamer binding | ![]() |
![]() |
2 | 2 | ||||||
MIRT443554 | ZFP3 | ZFP3 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT445953 | MLLT11 | MLLT11, transcription factor 7 cofactor | ![]() |
![]() |
2 | 2 | ||||||
MIRT446042 | HMCN1 | hemicentin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447968 | MSH6 | mutS homolog 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448634 | ONECUT1 | one cut homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449316 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT451380 | C19orf43 | telomerase RNA component interacting RNase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451547 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451807 | CDCA3 | cell division cycle associated 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT451916 | ILK | integrin linked kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451938 | TMPRSS5 | transmembrane protease, serine 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452189 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452498 | HMGXB3 | HMG-box containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452548 | ZNF467 | zinc finger protein 467 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453844 | SDK1 | sidekick cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454515 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455363 | KDM5C | lysine demethylase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT455455 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT455628 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | ![]() |
![]() |
2 | 10 | ||||||
MIRT455639 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT455690 | GLO1 | glyoxalase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT456300 | ASH1L | ASH1 like histone lysine methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT456784 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT456819 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT457566 | ZNF34 | zinc finger protein 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457604 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT458236 | NXPH3 | neurexophilin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458313 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458350 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT458670 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459675 | VPS37C | VPS37C, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT461126 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT461918 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462301 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | ![]() |
![]() |
2 | 2 | ||||||
MIRT463520 | ZBTB7B | zinc finger and BTB domain containing 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464378 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464614 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464711 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465520 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465974 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT466058 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466548 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466647 | TAGLN2 | transgelin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467357 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT468744 | SDC2 | syndecan 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470244 | PRRC2A | proline rich coiled-coil 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT471426 | PDIA6 | protein disulfide isomerase family A member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471732 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472190 | NHP2L1 | small nuclear ribonucleoprotein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472450 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT474563 | KLHDC3 | kelch domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474936 | KCTD15 | potassium channel tetramerization domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475165 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475399 | ICMT | isoprenylcysteine carboxyl methyltransferase | ![]() |
![]() |
2 | 4 | ||||||
MIRT475426 | ICK | intestinal cell kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT477090 | FAM168A | family with sequence similarity 168 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT478458 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT478953 | COX15 | COX15, cytochrome c oxidase assembly homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT480096 | CALR | calreticulin | ![]() |
![]() |
2 | 2 | ||||||
MIRT481924 | ANKRD33B | ankyrin repeat domain 33B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483217 | APOA1 | apolipoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT483882 | TGIF1 | TGFB induced factor homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483923 | SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483942 | LENG8 | leukocyte receptor cluster member 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484209 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484512 | SYT7 | synaptotagmin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484709 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485356 | MYO1C | myosin IC | ![]() |
![]() |
2 | 4 | ||||||
MIRT485615 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT486584 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487013 | C2orf82 | chromosome 2 open reading frame 82 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487621 | C20orf96 | chromosome 20 open reading frame 96 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487801 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488134 | GPR107 | G protein-coupled receptor 107 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488773 | FXYD1 | FXYD domain containing ion transport regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488854 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT489783 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490102 | FN3K | fructosamine 3 kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT490389 | LHFPL3 | LHFPL tetraspan subfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490434 | MYL9 | myosin light chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490451 | GLUD1 | glutamate dehydrogenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490880 | OSBP | oxysterol binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT491037 | ALPK3 | alpha kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491250 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491748 | SEMA3F | semaphorin 3F | ![]() |
![]() |
2 | 2 | ||||||
MIRT492235 | SLC48A1 | solute carrier family 48 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492490 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492505 | RANBP10 | RAN binding protein 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT492773 | PDGFB | platelet derived growth factor subunit B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492922 | NFAT5 | nuclear factor of activated T-cells 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493459 | ITFG3 | family with sequence similarity 234 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT493654 | HDLBP | high density lipoprotein binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT494011 | DUSP9 | dual specificity phosphatase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499412 | PLCG2 | phospholipase C gamma 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT499552 | C15orf43 | telomere repeat binding bouquet formation protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501836 | NCOA2 | nuclear receptor coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501950 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT504066 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504509 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508466 | HOXB6 | homeobox B6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512373 | CPM | carboxypeptidase M | ![]() |
![]() |
2 | 2 | ||||||
MIRT513578 | EVX1 | even-skipped homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517763 | ZNF366 | zinc finger protein 366 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519773 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 8 | ||||||
MIRT523568 | GGCX | gamma-glutamyl carboxylase | ![]() |
![]() |
2 | 4 | ||||||
MIRT532802 | CLDN11 | claudin 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544299 | TSPYL1 | TSPY like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544862 | MYH2 | myosin heavy chain 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556731 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT564347 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568924 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569012 | CXorf36 | chromosome X open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569256 | FAM129B | family with sequence similarity 129 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT569591 | PRELP | proline and arginine rich end leucine rich repeat protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT569779 | SAMD14 | sterile alpha motif domain containing 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570034 | FAM228A | family with sequence similarity 228 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT573803 | FRMPD4 | FERM and PDZ domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574190 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576153 | Hmox1 | heme oxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611311 | CA8 | carbonic anhydrase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT673429 | APAF1 | apoptotic peptidase activating factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674976 | SH3BP2 | SH3 domain binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692712 | MEAF6 | MYST/Esa1 associated factor 6 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|